Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$7.67
Day's range
$8.08

Eupraxia Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BEUTEL, GOODMAN & CO LTD. 05/15/2026 3.67 M $26.38 M   -1.16% 9.18%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 1.59 M $11.50 M   429.67% 3.98%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 1.35 M $9.77 M   0.00% 3.38%
VIVO CAPITAL, LLC 05/20/2026 1.35 M $9.77 M   0.00% 3.38%
SCOTIA CAPITAL INC. 05/13/2026 1.34 M $7.24 M   4.35% 3.36%
IKARIAN CAPITAL, LLC 05/15/2026 1.21 M $8.79 M   99.14% 3.04%
GREAT POINT PARTNERS LLC 05/15/2026 1.20 M $8.69 M   0.00% 3.00%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 967.58 K $7.01 M   35.88% 2.42%
UBS GROUP AG 05/05/2026 762.64 K $5.52 M   246.61% 1.91%
REDMILE GROUP, LLC 05/15/2026 700.00 K $5.07 M   100.00% 1.75%
RUBRIC CAPITAL MANAGEMENT LP 05/15/2026 691.17 K $5.00 M   100.00% 1.73%
05/15/2026 680.00 K $4.92 M   36.00% 1.70%
ALLY BRIDGE GROUP (NY) LLC 05/18/2026 660.38 K $4.78 M   65.97% 1.65%
PFM HEALTH SCIENCES, LP 05/15/2026 540.87 K $3.92 M   100.00% 1.35%
AMERIPRISE FINANCIAL INC 05/15/2026 524.26 K $3.80 M   100.00% 1.31%
WOODLINE PARTNERS LP 05/15/2026 440.55 K $3.19 M   100.00% 1.10%
06/04/2026 433.52 K $3.14 M   100.00% 1.09%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 375.00 K $2.72 M   100.00% 0.94%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 05/15/2026 352.00 K $2.55 M   0.00% 0.88%
SUMMITTX CAPITAL, L.P. 05/15/2026 328.00 K $2.37 M   86.42% 0.82%
AISLING CAPITAL MANAGEMENT LP 05/05/2026 325.00 K $2.35 M   100.00% 0.81%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 323.84 K $2.34 M   107.15% 0.81%
DV TRADING LLC 05/15/2026 276.00 K $2.00 M   100.00% 0.69%
BANK OF AMERICA CORP /DE/ 05/18/2026 268.22 K $1.94 M   5.88% 0.67%
ROYAL BANK OF CANADA 05/15/2026 261.38 K $1.89 M   33.17% 0.65%
CITADEL ADVISORS LLC 05/15/2026 230.18 K $1.67 M   100.00% 0.58%
MARSHALL WACE, LLP 05/15/2026 158.13 K $1.14 M   0.00% 0.40%
CIBC WORLD MARKET INC. 05/14/2026 150.95 K $1.09 M   160.03% 0.38%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 93.60 K $671.00 K   -39.91% 0.23%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 92.35 K $668.59 K   100.00% 0.23%
TD WATERHOUSE CANADA INC. 05/12/2026 81.73 K $589.80 K   751.30% 0.20%
INGALLS & SNYDER LLC 05/13/2026 75.65 K $548.00 K   -2.26% 0.19%
1832 ASSET MANAGEMENT L.P. 05/14/2026 60.00 K $434.40 K   86.69% 0.15%
GOLDMAN SACHS GROUP INC 05/15/2026 53.08 K $384.30 K   -8.57% 0.13%
RAYMOND JAMES FINANCIAL INC 05/14/2026 50.56 K $366.06 K   -4.55% 0.13%
DIADEMA PARTNERS LP 05/15/2026 40.00 K $289.60 K   100.00% 0.10%
BANK OF MONTREAL /CAN/ 05/13/2026 38.25 K $276.12 K   2.68% 0.10%
PERSISTENT ASSET PARTNERS LTD 05/12/2026 37.93 K $274.58 K   100.00% 0.09%
JANE STREET GROUP, LLC 05/12/2026 35.21 K $254.03 K   18.86% 0.09%
TORONTO DOMINION BANK 05/15/2026 32.90 K $237.48 K   100.00% 0.08%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 25.61 K $185.44 K   84.28% 0.06%
AXQ CAPITAL, LP 05/13/2026 15.76 K $114.10 K   100.00% 0.04%
INTEGRATED WEALTH CONCEPTS LLC 05/15/2026 12.00 K $86.88 K   100.00% 0.03%
TCI WEALTH ADVISORS, INC. 04/27/2026 11.00 K $79.64 K   0.00% 0.03%
TWO SIGMA INVESTMENTS, LP 05/15/2026 10.80 K $78.19 K   100.00% 0.03%
APTUS CAPITAL ADVISORS, LLC 05/11/2026 10.50 K $76.02 K   5.00% 0.03%
GUARDIAN WEALTH ADVISORS, LLC / NC 05/15/2026 10.50 K $76.02 K   5.00% 0.03%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 04/28/2026 10.00 K $72.40 K   100.00% 0.03%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 05/14/2026 9.09 K $49.03 K   0.00% 0.02%
MORGAN STANLEY 05/15/2026 8.82 K $63.86 K   100.00% 0.02%

Eupraxia Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 55 institutional investors and hedge funds held shares of Eupraxia Pharmaceuticals Inc. The most heavily invested institutionals were:

Beutel, Goodman & Co Ltd.: 3.67 M

Affinity Asset Advisors, LLC: 1.59 M

Vivo Capital, LLC: 1.35 M

BALYASNY ASSET MANAGEMENT L.P.: 1.35 M

SCOTIA CAPITAL INC.: 1.34 M

Ikarian Capital, LLC: 1.21 M

55.02% of Eupraxia Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 20.87 M shares in the last 24 months. This purchase volume represents approximately $163.21 M in transactions.